Stopped: Loss of funding
This clinical trial studies an imaging technique known as dynamic contrast enhanced magnetic resonance imaging (DCE MRI) in identifying the presence of pancreatic cancer. DCE MRI is a procedure that takes detailed pictures of functional and structural properties inside the body using magnetic field imaging. These images may better characterize pancreatic cancer in patients at high risk or in patients who may have undergone chemotherapy for pancreatic cancer.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Presence of pancreatic cancer (yes or no) for patients that are either at high risk for hereditary pancreatic cancer (Group I)
Timeframe: Up to 5 years
Presence of pancreatic cancer (yes or no) for patients with cystic lesions of the pancreas (Group II)
Timeframe: Up to 5 years
Change in tumor margins in patients who have undergone chemotherapy for pancreatic cancer (Group III)
Timeframe: Baseline to up to 2 years